CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing – KULR-TV
|
CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing
KULR-TV BASEL, Switzerland, March 28, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP) reported that the European Patent Office (EPO) has announced its intention to grant a patent broadly covering CRISPR's in-licensed gene editing … |
